Inhibition of age-induced β-Amyloid neurotoxicity in rat hippocampal cells

Experimental Neurology

Volumn 138, Issue 1, 1996, Pages 73-81

  Puttfarcken, Pamela S ^a   Manelli, Arlene M ^a   Neilly, Joseph ^a   Frail, Donald E ^b  

^a ABBOTT LABORATORIES   (United States)

^b WYETH AYERST RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; FREE RADICAL;

AGING; ALZHEIMER DISEASE; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CONTROLLED STUDY; EMBRYO; HIPPOCAMPUS; NERVE CELL; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0029670228     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1996.0048     Document Type: Article

References (38)

1. ARISPE, N., E. ROJAS, AND H. B. POLLARD. 1993. Alzheimer disease amyloid β protein forms calcium channels in bilayer membranes: Blockade by tromethamine and aluminum. Proc. Natl. Acad. Sci. USA 90: 567-571.
2. BEHL, C., J. DAVIS, G. M. COLE, AND D. SCHUBERT. 1992. Vitamin E protects nerve cells from amyloid β protein toxicity. Biochem. Biophys. Res. Commun. 186: 944-952.
3. BEHL, C., J. B. DAVIS, R. LESLEY, AND D. SCHUBERT. 1994. Hydrogen peroxide mediates amyloid β protein toxicity. Cell 77: 817-827.
4. BREWER, G. J., J. R. TORRICELLI, E. K. EVEGE, AND P. J. PRICE. 1993. Optimized survival of hippocampal neurons in B27-supplemented neurobasal, a new serum-free medium combination. J. Neurosci. Res. 35: 567-576.
5. CATALDO, M. C., P. A. PASKEVICH, E. KOMINAMI, AND R. A. NIXON. 1992. Lysosomal hydrolases of different classes are abnormally distributed in brains of patients with Alzheimer's disease. Proc. Natl. Acad. Sci. USA 88: 10998-11002.
6. CHARTIER-HARLIN, M.-C., F. CRAWFORD, H. HOULDEN, A. WARREN, D. HUGHES, L. FIDANI, A. GOATE, M. ROSSOR, P. ROQUES, J. HARDY, AND M. MULLAN. 1991. Early-onset Alzheimer's disease caused by mutations at codon 717 of the β-amyloid precursor protein gene. Nature 353: 844-846.
7. COYLE, J. T., AND P. S. PUTTFARCKEN. 1993. Oxidative stress, glutamate, and neuro-degeneration disorders. Science 262: 689-695.
8. DAVIDSON, R. M., L. SHAJENKO, AND T. S. DONTA. 1994. Amyloid beta-peptide (AβP) potentiates a nimodipine-sensitive L-type barium conductance in N1E-115 neuroblastoma cells. Brain Res. 643: 324-327.
9. DYRKS, T., E. DYRKS, T. HARTMANN, C. MASTERS, AND K. BEYREUTHER 1992. Amyloidogenicity of βA4 and βA4-bearing amyloid protein precursor fragments by metal-catalyzed oxidation. J. Biol. Chem. 267: 18210-18217.
10. DYRKS, T., E. DYRKS, C. L. MASTERS, AND K. BEYREUTHER. 1993. Amyloidogenicity of rodent and human βA4 sequences. FEBS Lett. 324: 231-236.
11. GLENNER, G. G., AND W. WONG. 1984. Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 120: 885-890.
12. GOATE, A., M.-C. CHARTIER-HARLIN, M. MULLAN, J. BROWN, F. CRAWFORD, L. FIDANI, L. GIUFFRA, A. HAYNES, N. IRVING, L. JAMES, R. MANT, P. NEWTON, K. ROOKE, P. ROQUES, C. TALBOT, M. PERICAK-VANCE, A. ROSES, R. WILLIAMSON, M. ROSSOR, M. OWEN, AND J. HARDY. 1991. Segregation of a missense mutation in the amyloid precursor protein. Biochem. Biophys. Res. Commun. 155: 608-614.
13. GOODMAN, Y., M. R. STEINER, AND S. M. STEINER, AND M. P. MATTSON. 1994. Nordihydroguaiaretic acid protects hippocampal neurons against amyloid β-peptide toxicity, and attenuates free radical and calcium accumulation. Brain Res. 654: 171-176.
14. HAASS, C., M. G. SCHLOSSMACHER, A. Y. HUNG, C. VIGO-PELFREY, A. MELLON, B. L. OSTASZEWSKI, I. LIEBERBURG, E. H. KOO, D. SCHENK, D. B. TEPLOW, AND D. J. SELKOE. 1992. Amyloid β-peptide is produced by cultured cells during normal metabolism. Nature 359: 322-325.
15. HARRIS, M. E., K. HENSLEY, D. A. BUTTERFIELD, R. A. LEEDLE, AND J. M. CARNEY. 1995. Direct evidence of oxidative injury produced by the Alzheimer's β-amyloid peptide (1-40) in cultured hippocampal neurons. Exp. Neurol. 131: 193-202.
16. HENSLEY, K., J. M. CARNEY, M. P. MATTSON, M. AKSENOVA, M. HARRIS, J. F. WU, R. A. FLOYD, AND D. A. BUTTERFIELD. 1994. A model for β-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: Relevance to Alzheimer disease. Proc. Natl. Acad. Sci. USA 91: 3270-3274.
17. IWATSUBO, T., D. M. MANN, A. ODAKA, N. SUZUKI, AND Y. IHARA. 1995. Amyloid β protein (Aβ) deposition: Aβ42(43) precedes Aβ40 in Down syndrome. Ann. Neurol. 37: 294-299.
18. IWATSUBO, T., A. ODAKA, N. SUZUKI, H. MIZUSAWA, N. NUKINA, AND Y. IHARA. 1994. Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: Evidence that an initially deposited species is Aβ42(43). Neuron 13: 45-53.
19. KIMURA, H., AND D. SCHUBERT. 1993. Amyloid β protein activates tachykinin receptors and IP3 accumulation by synergy with glutamate. Proc. Natl. Acad. Sci. USA 90: 7508-7512.
20. KOH, J., L. L. YANG, AND C. W. COTMAN. 1990. β-Amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage. Brain Res. 533: 315-320.
21. MATTSON, M. P., B. CHENG, D. DAVIS, K. BRYANT, I. LIEDERBURG, AND R. RYDEL. 1992. β-Amyloid peptides destabilize calcium homeostasis and render cortical neurons more vulnerable to excitotoxicity. J. Neurosci. 12: 376-389.
22. MAY, P. C., B. D. GITTER, D. C. WATERS, L. K. SIMMONS, G. W. BECKER, J. S. SMALL, AND P. M. ROBINSON. 1992. β-Amyloid peptide in vitro toxicity: Lot to lot variability. Neurobiol. Aging 13: 605-607.
23. MURRELL, J., M. FARLOW, B. GHETTI, AND M. BENSON. 1991. A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease. Science 254: 97-99.
24. PACKER, L., M. VALENZA, E. SERBINOVA, P. STARKE-REED, K. FROST, AND V. KAGAN. 1991. Free radical scavenging is involved in the protective effect of L-propionylcarnitine against ischemia-reperfusion injury of the heart. Arch. Biochem. Biophys. 238: 533-537.
25. PAPPOLLA, M. A., R. A. OMAR, K. S. KIM, AND N. K. ROBAKIS. 1992. Immunohistochemical evidence of antioxidant stress in Alzheimer's disease. Am. J. Pathol. 140(5): 621-628.
26. PIKE, C. J., A. J. WALENCEWICZ, C. G. GLABE, AND C. W. COTMAN. 1991. Aggregation-related toxicity of synthetic β-amyloid protein in hippocampal cultures. Eur. J. Pharmacol. 207: 367-368.
27. PIKE, C. J., A. J. WALENCEWICZ, C. G. GLABE, AND C. W. COTMAN. 1991. In vitro aging of β-amyloid protein caused protein aggregation and neurotoxicity. Brain Res. 563: 311-314.
28. PIKE, C. J., D. BURDICK, A. J. WALENCEWICZ, C. G. GLABE, AND C. W. COTMAN. 1993. Neurodegeneration induced by β-amyloid peptides in vitro: The role of peptide assembly state. J. Neurosci. 13: 1676-1687.
29. RICHARDSON, J. S. 1994. Free radicals in the genesis of Alzheimer's disease. Ann. N.Y. Acad. Sci. 695: 73-76.
30. ROGERS, J., N. R. COOPER, S. WEBSTER, J. SCHULTZ, P. L. MCGEER, S. D. STRYREN, W. H. CIVIN, L. BRACHOVA, B. BRADT, P. WARD, AND I. LIEBERBURG. 1992. Complement activation by β-amyoid in Alzheimer's disease. Proc. Natl. Acad. Sci. USA 89: 10016-10020.
31. SELKOE, D. J. 1991. The molecular pathology of Alzheimer's disease. Neuron 6: 487-498.
32. SEUBERT, P., C. VIGO-PELFREY, F. ESCH, M. LEE, H. DOVEY, D. DAVIS, S. SINHA, M. SCHLOSSMACHER, J. WHALEY, M. SWINDLEHURST, R. MCCORMACK, R. WOLFERT, D. SELKOE, I. LIEBERBURG, AND D. SCHENK. 1992. Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids. Nature 359: 325-327.
33. SIMS, N. R., J. M. FINEGAN, J. P. BLASS, D. M. BOWEN, AND D. NEARY. 1987. Mitochondrial function in brain tissue in primary degenerative dementia. Brain Res. 436: 30-38.
34. SIMMONS, L. K., P. C. MAY, K. J. TOMASELLI, R. E. RYDEL, K. S. FUSON, E. F. BRIGHAM, S. WRIGHT, I. LIEBERBURG, G. W. BECKER, D. N. BREMS, AND W. Y. LI. 1994. Secondary structure of amyloid β peptide correlates with neurotoxic activity in vitro. Mol. Pharmacol. 45: 373-379.
35. WHITSON, J. S., D. J. SELKOE, AND C. W. COTMAN. 1989. Amyloid β protein enhances the survival of hippocampal neurons in vitro. Science 243: 1488-1490.
36. WISNIEWSKI, K., H. WISNIEWSKI, AND G. WEN. 1985. Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome. Ann. Neurol. 17: 278-282.
37. YANKNER, B. A. 1992. Commentary and perspective on studies of beta amyloid neurotoxicity. Neurobiol. Aging. 13: 615-616.
38. YANKNER, B. A., L. K. DUFFY, AND D. A. KIRSCHNER. 1990. Neurotrophic and neurotoxic effects of amyloid β protein: Reversal by tachykinin neuropeptides. Science 250: 279-282.